載入...
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high morbidity and mortality worldwide. Chemotherapy is recommended to patients with intermediate or advanced stage cancer. However, the conventional chemotherapy yields low desired response rates due to multidrug resistance...
Na minha lista:
| 發表在: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5127222/ https://ncbi.nlm.nih.gov/pubmed/27920520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S115727 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|